Filed by the Registrant ☒ | Filed by a party other than the Registrant ☐ |
☐ |
Preliminary Proxy Statement
|
☐ |
Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
|
☒ |
Definitive Proxy Statement
|
☐ |
Definitive Additional Materials
|
☐ |
Soliciting Material under § 240.14a-12
|
☒ |
No fee required.
|
|
☐ |
Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11.
|
|
(1)
|
Title of each class of securities to which transaction applies:
|
|
(2)
|
Aggregate number of securities to which transaction applies:
|
|
(3)
|
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined):
|
|
(4)
|
Proposed maximum aggregate value of transaction:
|
|
(5)
|
Total fee paid:
|
|
☐ |
Fee paid previously with preliminary materials.
|
|
☐ |
Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or
Schedule and the date of its filing.
|
|
(1)
|
Amount Previously Paid:
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
|
(3)
|
Filing Party:
|
|
(4)
|
Date Filed:
|
|
|
Sincerely,
|
|
![]() |
|
Christopher Lien
|
|
Chief Executive Officer
|
Time and Date:
|
Wednesday, May 27, 2020 at 9:30 a.m. Pacific Daylight Time
|
Place:
|
Virtual meeting via a live interactive webcast on the Internet at www.virtualshareholdermeeting.com/MRIN2020 (the “Annual Meeting”)
|
Items of Business:
|
1. Elect two Class I directors of Marin Software Incorporated, each to serve until the 2023 annual meeting of stockholders and until his successor has been elected and qualified or until
his earlier resignation or removal.
2. Vote, on a non-binding advisory basis, on the compensation paid by us to our named executive officers for the year ended December 31, 2019.
3. Vote, on a non-binding advisory basis, on the frequency of future advisory votes on executive compensation.
4. Ratify the appointment of Grant Thornton LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2020.
5. Transact any other business as may properly come before the meeting or any adjournment or postponement of the Annual Meeting.
|
Record Date:
|
Only stockholders of record at the close of business on April 8, 2020 are entitled to notice of, and to vote at, the Annual Meeting and any adjournments thereof.
|
Proxy Voting:
|
Each share of common stock that you own represents one vote. For questions regarding your stock ownership, you may contact the Marin Software Investor Relations Department through our website at http://investor.marinsoftware.com/contact-ir
or, if you are a registered holder, our transfer agent, Broadridge Corporate Issuer Solutions, Inc., by email through its website at www.shareholder@broadridge.com or by phone at (877) 830-4936.
|
|
By Order of the Board of Directors,
|
|
![]() |
|
Christopher Lien
|
|
Chief Executive Officer
|
1
|
||
1
|
||
1
|
||
5
|
||
5
|
||
5
|
||
5
|
||
5
|
||
6
|
||
8
|
||
8
|
||
8
|
||
8
|
||
8
|
||
9
|
||
9
|
||
9
|
||
9
|
||
10
|
||
10
|
||
11
|
||
12
|
||
14
|
||
15
|
||
16
|
||
16
|
||
16
|
||
17
|
||
19
|
||
20
|
||
20
|
||
20
|
||
22
|
||
23
|
||
24
|
||
26
|
||
27
|
||
28
|
||
28
|
||
29
|
||
30
|
||
30
|
||
30
|
||
30
|
||
30
|
||
30
|
||
31
|
• |
Proposal 1: FOR each of the Class I directors named in this proxy statement
|
• |
Proposal 2: FOR the approval of the compensation of our named executive officers as disclosed in this proxy statement
|
• |
Proposal 3: FOR “ONE YEAR” as the frequency with which stockholders are provided an advisory
vote on executive compensation
|
• |
Proposal 4: FOR the ratification of the appointment of Grant Thornton LLP as our independent registered public accounting firm for
the fiscal year ending December 31, 2020.
|
• |
vote at the Meeting—by following the instructions at www.virtualshareholdermeeting.com/MRIN2020, where stockholders may vote and submit questions during the Meeting. The Meeting starts at 9:30
a.m. Pacific Daylight Time on May 27, 2020. Please have your 16-Digit Control Number to join the Meeting. Instructions on how to attend and participate via the Internet, including how to demonstrate proof of stock ownership, are posted
at www.proxyvote.com;
|
• |
vote via telephone or the Internet—in order to do so, please follow the instructions shown on your proxy card; or
|
• |
vote by mail—if you request or receive a paper proxy card and voting instructions by mail, simply complete, sign and date the enclosed proxy card and return it before the Meeting in the envelope provided.
|
• |
selecting a firm to serve as the independent registered public accounting firm to audit our financial statements and overseeing their work;
|
• |
reviewing the continuing independence of the independent registered public accounting firm;
|
• |
discussing the scope and results of the audit with the independent registered public accounting firm, and reviewing, with management and that firm, our interim and year-end operating results;
|
• |
establishing procedures for employees and others to submit anonymously concerns about questionable accounting or audit matters;
|
• |
considering and reviewing the adequacy of our disclosure controls and internal controls over financial reporting;
|
• |
reviewing material related party transactions or those that require disclosure; and
|
• |
approving or, as permitted, pre-approving all audit and non-audit services to be performed by the independent registered public accounting firm.
|
• |
reviewing and approving, or recommending that our Board approve, the compensation of our executive officers;
|
• |
reviewing and approving, or recommending to our Board the compensation of our directors;
|
• |
reviewing and approving, or recommending to our Board the terms of any compensatory agreements with our executive officers;
|
• |
administering our stock and equity incentive plans;
|
• |
reviewing and approving, or making recommendations to our Board with respect to, cash-based and equity-based incentive compensation; and
|
• |
reviewing our overall compensation strategy.
|
• |
provide compensation-related data for a peer group of companies to serve as a basis for assessing competitive compensation practices;
|
• |
review and assess our current executive officer compensation policies and practices and equity profile relative to market practices; and
|
• |
review and assess our current executive compensation program relative to market to identify any potential changes or enhancements to be brought to the attention of the compensation committee.
|
• |
identifying, evaluating, recruiting, and recommending candidates for membership on our Board;
|
• |
reviewing and recommending changes to our Corporate Governance Guidelines and Codes of Conduct and Business Ethics for Directors and for Employees;
|
• |
reviewing proposed waivers of the Code of Conduct for Directors;
|
• |
overseeing the process of evaluating the performance of our Board; and
|
• |
assisting our Board on corporate governance matters.
|
• |
our Board held five meetings and acted by unanimous written consent seven times;
|
• |
our audit committee held seven meetings;
|
• |
our compensation committee held three meetings and acted by unanimous written consent two times; and
|
• |
our nominating and corporate governance committee did not hold any meetings and acted by unanimous written consent one time.
|
Name of Director/Nominee
|
Age
|
Principal Occupation
|
Director Since
|
|||
L. Gordon Crovitz(1) (2)
|
61
|
Founder, Journalism Online
|
2012
|
|||
Daina Middleton(1) (2) (3)
|
54
|
Partner, Enact Agency
|
2014
|
(1)
|
Member of audit committee.
|
(2) |
Member of nominating and corporate governance committee.
|
(3) |
Member of compensation committee.
|
Name of Director
|
Age
|
Principal Occupation
|
Director Since
|
|||
Class II Director:
|
||||||
Donald Hutchison(1)
|
63
|
Investor
|
2006
|
Class III Directors:
|
||||||
Brian Kinion(2)
|
53
|
CFO, Upwork
|
2017
|
|||
Chris Lien
|
53
|
Founder, CEO, Marin Software Incorporated
|
2006
|
(1)
|
Member of compensation committee.
|
(2) |
Member of audit committee.
|
Name
|
Fees Earned
or Paid in
Cash ($)
|
Option
Awards
($)(1)
|
All Other
Compensation
($)
|
Total ($)
|
||||||||||||
L. Gordon Crovitz
|
—
|
34,837
|
—
|
34,837
|
||||||||||||
Donald P. Hutchison
|
—
|
34,837
|
—
|
34,837
|
||||||||||||
Brian Kinion
|
—
|
34,837
|
—
|
34,837
|
||||||||||||
Daina Middleton
|
—
|
34,837
|
—
|
34,837
|
(1) |
Amounts shown in this column reflect the aggregate full grant date fair value calculated in accordance with ASC 718 for stock option awards granted during the fiscal year. The assumptions used in calculating the
grant date fair value of the stock options reported in this column are set forth in Notes 11 and 12 to the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2019 (the
“2019 Form 10-K”). Note that the amounts reported in this column reflect the accounting cost for these stock options, and do not correspond to the actual economic value that may be received by the non-employee directors from the options.
For information regarding the number of stock options held by each non-employee director as of December 31, 2019, see the table below.
|
Name
|
Grant Date
|
Option
Awards(1)
|
||
L. Gordon Crovitz
|
5/13/19(2)
|
16,900
|
||
4/12/18(2)
|
8,572
|
|||
5/8/17(2)
|
8,572
|
|||
5/10/16(2)
|
8,572
|
|||
4/22/15(2)
|
6,943
|
|||
5/12/14(2)
|
4,177
|
|||
Donald P. Hutchison
|
5/13/19(2)
|
16,900
|
||
4/12/18(2)
|
8,572
|
|||
5/8/17(2)
|
8,572
|
|||
5/10/16(2)
|
8,572
|
|||
4/22/15(2)
|
6,986
|
|||
5/12/14(2)
|
4,220
|
|||
9/14/12(3)
|
2,858
|
|||
1/31/13(4)
|
4,286
|
|||
1/31/13(5)
|
100
|
|||
Brian Kinion
|
5/13/19(2)
|
16,900
|
||
4/12/18(2)
|
8,572
|
|||
8/15/17(2)
|
7,444
|
|||
Daina Middleton
|
5/13/19(2)
|
16,900
|
||
4/12/18(2)
|
8,572
|
|||
5/8/17(2)
|
8,572
|
|||
5/10/16(2)
|
8,572
|
|||
4/22/15(2)
|
6,886
|
|||
10/13/14(6)
|
4,286
|
(1) |
All stock options expire 10 years after the date of grant. These stock options also provide that, in the event of a “change of control,” all of the shares of our common stock subject to such stock option will
immediately vest, and the right of repurchase with respect to any unvested shares shall lapse, in full as of the effectiveness of the change of control. All historic stock option awards listed in this table have been adjusted to reflect
our 1-for-7 reverse stock split effectuated on October 5, 2017.
|
(2) |
The stock option was granted pursuant to the 2013 Plan and vested or will vest in its entirety on the first anniversary of the vesting commencement date.
|
(3) |
The stock option was granted pursuant to the 2006 Equity Incentive Plan (the “2006 Plan”) and was immediately exercisable in full upon grant. In the event the grantee exercised unvested shares subject to the
option, the unvested shares would be subject to a right of repurchase in our favor at the option exercise price. The stock option vested ratably each month over a 48-month period from the vesting commencement date.
|
(4) |
The stock option was granted pursuant to the 2006 Plan and was immediately exercisable in full upon grant. In the event the grantee exercised unvested shares subject to the option, the unvested shares would be
subject to a right of repurchase in our favor at the option exercise price. The stock option vested over a three-year period with one-third vesting on each anniversary of the vesting commencement date and is fully vested.
|
(5) |
The stock option was granted pursuant to the 2006 Plan and was immediately exercisable in full upon grant. In the event the grantee exercised unvested shares subject to the option, the unvested shares would be
subject to a right of repurchase in our favor at the option exercise price. The stock option vested in its entirety on the first anniversary of the vesting commencement date.
|
(6) |
The stock option was granted pursuant to the 2013 Plan and vests over a three-year period with one-third vesting on each anniversary of the vesting commencement date.
|
Fees Billed to Marin
|
Fiscal 2018
|
Fiscal 2019
|
||||||
Audit fees(1)
|
$
|
982,500
|
$
|
741,900
|
||||
Audit-related fees
|
—
|
—
|
||||||
Tax fees(2)
|
75,200
|
5,200
|
||||||
Total fees
|
$
|
1,057,700
|
$
|
747,100
|
(1) |
“Audit fees” include fees for audit services primarily related to the audit of our annual consolidated financial statements; the review of our
quarterly consolidated financial statements; comfort letters, consents, and assistance with and review of documents filed with the SEC; and other accounting and financial reporting consultation and research work billed as audit fees or
necessary to comply with the standards of the Public Company Accounting Oversight Board (United States).
|
(2) |
“Tax fees” include fees for tax compliance and advice, and encompass a variety of permissible tax services, including technical tax advice related
to federal and state income tax matters, assistance with sales tax, and assistance with tax audits. In fiscal 2018 and 2019, “tax fees”
included analysis related to our corporate tax structure.
|
• |
each stockholder known by us to be the beneficial owner of more than 5% of our common stock;
|
• |
each of our current directors or director nominees;
|
• |
each of our named executive officers during fiscal 2019; and
|
• |
all of our directors, director nominees and executive officers as a group.
|
Name of Beneficial Owner
|
Number of
Shares
Beneficially
Owned
|
Percent Owned
|
||
Directors and Named Executive Officers
|
||||
L. Gordon Crovitz(1)
|
53,819
|
*
|
||
Donald P. Hutchison(2)
|
88,205
|
1.3
|
||
Brian Kinion(3)
|
16,016
|
*
|
||
Christopher Lien(4)
|
326,584
|
4.7
|
||
Daina Middleton(5)
|
36,888
|
*
|
||
Wister Walcott(6)
|
117,031
|
1.7
|
||
Robert Bertz
|
—
|
*
|
||
Bradley Kinnish(7)
|
62,147
|
*
|
||
All officers and directors as a group (7 persons)(8)
|
638,543
|
9.1
|
||
5% or Greater Stockholders
|
||||
Benchmark Capital Partners VI, L.P(9)
|
553,502
|
8.1
|
||
Entities affiliated with DAG Ventures(10)
|
543,024
|
8.0
|
||
ESW Capital, LLC(11)
|
579,000
|
8.5
|
* |
Represents beneficial ownership of less than 1% of our outstanding shares of common stock.
|
(1) |
Consists of (a) 16,982 shares of our common stock and (b) 36,837 shares of our common stock issuable upon exercise of stock options exercisable within 60 days of February 15, 2020.
|
(2) |
Consists of (a) 37,011 shares of our common stock held directly by the Hutchison Family Trust, of which Mr. Hutchison is a co-trustee, (b) 7,028 shares of our common stock held by Glasgow Investments, LLC and
(c) 44,166 shares of our common stock issuable to Mr. Hutchison upon exercise of stock options exercisable within 60 days of February 15, 2020. Mr. Hutchison is a managing member of Glasgow Investments, LLC and possesses the power to
direct the voting and disposition of the shares held by Glasgow Investments, LLC and as such may be deemed to beneficially own the shares of our common stock held by Glasgow Investments, LLC.
|
(3) |
Consists of 16,016 shares of our common stock issuable upon exercise of stock options exercisable within 60 days of February 15, 2020.
|
(4) |
Consists of (a) 235,643 shares of our common stock held directly by the Lien Revocable Trust dated 7/8/2003, of which Mr. Lien is a co-trustee, (b) 3,658 shares of our common stock held individually by Mr. Lien,
(c) 62,919 shares of our common stock issuable to Mr. Lien upon exercise of stock options exercisable within 60 days of February 15, 2020, (d) 12,182 shares of our common stock held by the Chris Lien 2013 Annuity Trust, and (e) 12,182
shares of our common stock held by the Rebecca Lien 2013 Annuity Trust.
|
(5) |
Consists of 36,888 shares of our common stock issuable upon exercise of stock options exercisable within 60 days of February 15, 2020.
|
(6) |
Consists of (a) 76,346 shares of our common stock, (b) 29,435 shares of our common stock issuable upon exercise of stock options exercisable within 60 days of February 15, 2020, and (c) 11,250 restricted stock
units subject to vesting within 60 days of February 15, 2020.
|
(7) |
Mr. Kinnish resigned as our Chief Financial Officer as of December 5, 2019. Consists of (a) 9,079 shares of our common stock, and (b) 53,068 shares of our common stock issuable upon exercise of stock options
exercisable within 60 days of February 15, 2020.
|
(8) |
Includes (a) 401,032 shares of common stock, (b) 226,261 shares issuable upon exercise of stock options exercisable within 60 days of February 15, 2020, and (c) 11,250 shares of our common stock subject to
vesting of restricted stock unit awards within 60 days of February 15, 2020.
|
(9) |
Based on information contained in a Schedule 13G/A filed with the SEC by Benchmark Capital on February 12, 2020. Consists of (a) 456,916 shares of our common stock held by Benchmark Capital Partners VI, L.P.
(“BCP VI”) and (b) 28,576 shares of our common stock held by Benchmark Founders’ Fund VI, L.P. (“BFF VI”), (c) 18,754 shares held by Benchmark Founders’ Fund VI-B L.P. (“BFF VI-B”) and (d) 49,256 shares of our common stock held in nominee
form for the benefit of persons associated with Benchmark Capital Management Co. VI, L.L.C. (“BCMC VI”). BCMC VI is the general partner of BCP VI, BFF VI and BFF VI-B and may be deemed to have sole voting and investment power over the
shares held by BCP VI, BFF VI and BFF VI-B. Certain individual members of BCMC VI, including Bruce W. Dunlevie, a member of our Board until February 2017, may be deemed to have shared voting and investment power over the shares held by
BCP VI, BFF VI and BFF VI-B. The address for each Benchmark reporting entity is 2965 Woodside Road, Woodside, California 94062.
|
(10) |
Based on information contained in a Schedule 13G filed with the SEC by DAG Ventures IV-QP, L.P. and its affiliates on February 11, 2014 and adjusted here for the 1-for-7 reverse stock split effectuated on
October 5, 2017. Consists of 444,674 shares of our common stock held by DAG Ventures IV-QP, L.P. (“DAVG IV-QP”), (b) 51,356 shares of our common stock held by DAG Ventures IV-A, LLC (“DAG IV-A”) and (c) 46,994 shares of our common stock
held by DAG Ventures IV, L.P. (“DAG IV”). DAG Ventures Management IV, LLC (“DAG IV LLC”) serves as the general partner of DAG IV-QP and DAG IV. As such, DAG IV LLC possesses power to direct the voting and disposition of the shares of our
common stock owned by DAG IV-QP and DAG IV and may be deemed to have indirect beneficial ownership of the shares of our common stock held by DAG IV-QP and DAG IV. DAG IV LLC does not own any of our securities directly. R. Thomas Goodrich,
John J. Caddo, Greg Williams, Young J. Chung and Nick Pianism are managing directors of DAG IV LLC and DAG IV-A and possess power to direct the voting and disposition of the shares owned by DAG IV-QP, DAG IV and DAG IV-A and may be deemed
to have indirect beneficial ownership of the shares held by DAG IV-QP, DAG IV and DAG IV-A. The address for DAG IV-QP, DAG IV, DAG IV-A and DAG IV LLC is 251 Lytton Avenue, Suite 200, Palo Alto, CA 94301.
|
(11) |
Based on information contained in a Schedule 13G filed with the SEC by ESW Capital, LLC (“ESW”) on December 28, 2018. ESW owns 579,000 shares. Joseph A. Liemandt is the sole voting member of ESW and may be
deemed to have indirect beneficial ownership of the shares held by ESW. The address for ESW and Mr. Liemandt is 401 Congress Avenue, Suite 2650, Austin, TX 78701.
|
Name
|
Age
|
Position
|
||
Christopher Lien
|
53
|
Chief Executive Officer
|
||
Robert Bertz
|
56
|
Chief Financial Officer
|
||
Wister Walcott
|
53
|
EVP, Product and Technology
|
• |
Christopher Lien, our founder and Chief Executive Officer;
|
• |
Wister Walcott, our Executive Vice President, Product and Technology;
|
• |
Robert Bertz, our Chief Financial Officer; and
|
• |
Bradly Kinnish, our former Chief Financial Officer.
|
Name and Principal Position
|
Year
|
Salary
($)
|
Bonus
($)
|
Stock
Awards
($)(1)
|
Option
Awards
($)(2)
|
Non-Equity
Incentive Plan
Compensation
($)(3)
|
All Other
Compensation
($)
|
Total
($)
|
||||||||||||||||||||||||
Christopher Lien
|
2019
|
400,000
|
—
|
—
|
123,682
|
300,000
|
32,651
|
(7)
|
856,333
|
|||||||||||||||||||||||
Founder, Chief Executive Officer
|
2018
|
400,000
|
—
|
—
|
—
|
288,000
|
32,617
|
(8)
|
720,617
|
|||||||||||||||||||||||
Wister Walcott
|
2019
|
300,000
|
—
|
180,000
|
(4)
|
—
|
112,500
|
3,283
|
(9)
|
595,783
|
||||||||||||||||||||||
EVP, Product & Technology
|
2018
|
300,000
|
—
|
297,000
|
(5)
|
—
|
108,000
|
2,837
|
(10)
|
707,837
|
||||||||||||||||||||||
Robert Bertz*
|
2019
|
169,861
|
—
|
143,200
|
(6)
|
—
|
35,859
|
15,488
|
(11)
|
364,408
|
||||||||||||||||||||||
Chief Financial Officer
|
||||||||||||||||||||||||||||||||
Bradley Kinnish**
|
2019
|
262,018
|
—
|
120,000
|
(14)
|
—
|
—
|
9,447
|
(12)
|
391,465
|
||||||||||||||||||||||
Former Chief Financial Officer
|
2018
|
275,000
|
—
|
—
|
238,651
|
99,000
|
9,016
|
(13)
|
621,667
|
*
|
Mr. Bertz was appointed as our Chief Financial Officer as of December 5, 2019.
|
**
|
Mr. Kinnish resigned as our Chief Financial Officer as of December 5, 2019.
|
(1) |
The amount shown in this column represents the grant date fair value of restricted stock units (“RSUs”) granted, as computed in accordance with ASC 718. For fiscal 2018, the assumptions used in calculating
the grant date fair value are set forth in Notes 10 and 11 to the audited consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2018 (the “2018 Form 10-K”). For fiscal 2019, the
assumptions used in calculating the grant date fair value are set forth in Notes 11 and 12 to the audited consolidated financial statements included in our 2019 Form 10-K. Note that the amount reported in this column reflects the
accounting cost for these RSUs and do not correspond to the actual economic value that may be received.
|
(2) |
The amounts shown in this column represent the grant date fair value of the stock options granted to the named executive officers during 2018 and 2019, as computed in accordance with ASC 718. For fiscal 2018,
the assumptions used in calculating the grant date fair value are set forth in Notes 10 and 11 to the audited consolidated financial statements included in the 2018 Form 10-K. For fiscal 2019 amounts, the assumptions used in calculating
the grant date fair value are set forth in Notes 11 and 12 to the audited consolidated financial statements included in our 2019 10-K. Note that the amounts reported in this column reflect the accounting cost for these stock options, and
do not correspond to the actual economic value that may be received by the named executive officers from the options.
|
(3) |
The amounts in this column represent total performance-based bonuses earned for services rendered in fiscal 2018 and fiscal 2019 pursuant to
the terms of our Executive Bonus Plan. For fiscal 2018, our Executive Bonus Plan funded at 72% attainment based on our revenue performance and ending cash balance. As a result, Messrs. Kinnish and Walcott received cash bonus amounts
equal to 72% of their respective target level of annual bonus, where the target was 50% of their respective annual base salaries. Mr. Lien received a cash bonus amount equal to 72% of his target level of annual bonus, where the target
was 100% of his annual base salary. Each of these bonuses was paid in fiscal 2019. For fiscal 2019, our revenue performance and ending cash balance resulted in 72% attainment of the goals originally established under the Executive Bonus
Plan. In June 2019, the Board approved a modification to the Executive Bonus Plan for 2019 (the “Modified Plan”), which applied to certain participants, including Mr. Kinnish (our then-current Chief Financial Officer) and Mr. Walcott
(the “Included Personnel”), but excluded Mr. Lien. The Board approved the Modified Plan to provide for a minimum payout percentage of 75% of each Included Personnel’s target annual bonus amount, regardless of the Company’s revenue and
ending cash balance as of December 31, 2019. Mr. Lien’s eligibility for a cash bonus would be determined in accordance with the Executive Bonus Plan for 2019, in its unmodified form. Messrs. Walcott and Kinnish had a target cash bonus
amount equal to 50% of his base salary. Mr. Robert Bertz, the Company’s current Chief Financial Officer, has had a target cash bonus amount equal to 50% of his base salary since his appointment as Chief Financial Officer on December 5,
2019. To assist with retention, in February 2020, the compensation committee funded the Modified Plan at 75% of the target level of funding for Messrs. Lien, Walcott and Bertz. Although Messrs. Lien and Bertz were not subject to the
Modified Plan providing for a minimum payout percentage of 75%, the Committee determined for retention purposes to grant cash bonuses to Messrs. Lien and Bertz at the same 75% of annual bonus target level as agreed for the Included
Personnel. Mr. Bertz’s cash bonus amount equaled 75% of his target level of annual bonus, prorated based on the partial year of service as Chief Financial Officer during fiscal 2019. Each of these bonuses was paid in fiscal 2020.
|
(4) |
Represents an RSU award with respect to 45,000 shares made at the discretion of the compensation committee on May 13, 2019, which vests as follows: 25% of the shares vest on May 13, 2020 and the remainder
vest annually over the next three years thereafter subject to Mr. Walcott continuing to provide services to the Company, such that the shares subject to this RSU would be fully vested in May 2023. The compensation committee awarded Mr.
Walcott the RSU grant to promote retention.
|
(5) |
Represents an RSU award with respect to 45,000 shares made at the discretion of the compensation committee on April 12, 2018, which vests as follows: 25% of the shares vested on April 12, 2019 and the
remainder vest annually over the next three years thereafter subject to Mr. Walcott continuing to provide services to the Company, such that the shares subject to this RSU would be fully vested in April 2022. The compensation committee
awarded Mr. Walcott the RSU grant to promote retention.
|
(6) |
Represents two RSU awards made to Mr. Bertz in 2019. The first RSU award with respect to 20,000 shares was made at the discretion of the compensation committee on May 7, 2019. This RSU is subject to
vesting, with 25% of the shares vesting on May 7, 2020 and the remainder vesting annually over the next three years thereafter subject to Mr. Bertz continuing to provide services to the Company, such that the shares subject to this RSU
would be fully vested in May 2023. The compensation committee awarded Mr. Bertz this RSU grant in connection with his joining the Company as Vice President and Corporate Controller in April 2019. The second RSU award with respect to an
additional 20,000 shares was made at the discretion of the Board of Directors December 9, 2019. This RSU is subject to vesting, with 25% of the shares vesting on December 9, 2020 and the remainder vesting annually over the next three
years thereafter subject to Mr. Bertz continuing to provide services to the Company, such that the shares subject to this RSU would be fully vested in December 2023. The Board of Directors awarded Mr. Bertz this RSU grant in connection
with his promotion to Chief Financial Officer in December 2019.
|
(7) |
Includes $29,368 in medical insurance premiums coverage that we paid on Mr. Lien’s behalf, $2,863 in premiums paid by us for long-term disability benefits, and $420 in premiums paid by us group term life
insurance benefits.
|
(8) |
Includes $27,777 in medical insurance premiums coverage that we paid on Mr. Lien’s behalf, $2,460 in parking reimbursement, and $2,381 in premiums paid by us for long-term disability benefits.
|
(9) |
Includes $2,863 in premiums paid by us for long-term disability benefits, and $420 in premiums paid by us group term life insurance benefits.
|
(10) |
Includes $456 in reimbursement for travel expenses incurred by Mr. Walcott and $2,381 in premiums paid by us for long-term disability benefits.
|
(11) |
Includes $13,911 in medical insurance premiums coverage that we paid on Mr. Bertz’s behalf, $995 in premiums paid by us for life insurance, and $582 in premiums paid by us for long-term disability benefits.
|
(12) |
Includes $7,896 in medical insurance premiums coverage that we paid on Mr. Kinnish’s behalf, $403 in premiums paid by us for life insurance, and $1,149 in premiums paid by us for long-term disability benefits.
|
(13) |
Includes $7,753 in medical insurance premiums coverage that we paid on Mr. Kinnish’s behalf, $540 in premiums paid by us for life insurance, and $723 in premiums paid by us for long-term disability benefits.
|
(14) |
Represents an RSU award with respect to 30,000 shares made at the discretion of the compensation committee on May
13, 2019, which vests as follows: 25% of the shares were to vest on May 13, 2020 and the remainder were to vest annually over the next three years thereafter subject to Mr. Kinnish continuing to provide services to the Company. The
compensation committee awarded Mr. Kinnish the RSU grant to promote retention. The award stopped vesting
when Mr. Kinnish resigned in December 2019.
|
Option Awards
|
Stock Awards
|
||||||||||||||||||||||
Number of Securities Underlying
Unexercised Options (#)(1) |
Option
Exercise
Price ($)
|
Option Expiration Date
|
Number of
Restricted
Stock
Units That
Have Not
Vested (#)
|
Market
Value of
Restricted
Stock Units
That Have
Not Vested
($)(2)
|
|||||||||||||||||||
Name
|
Exercisable
|
Unexercisable
|
|||||||||||||||||||||
Christopher Lien
|
7,143
|
—
|
68.18
|
5/11/24
|
—
|
—
|
|||||||||||||||||
10,428
|
—
|
45.36
|
3/8/25
|
—
|
—
|
||||||||||||||||||
8,572
|
—
|
15.05
|
5/9/26
|
—
|
—
|
||||||||||||||||||
36,776
|
—
|
49.35
|
5/7/22
|
—
|
—
|
||||||||||||||||||
—
|
60,000
|
|
(3)
|
4.00
|
5/13/29
|
||||||||||||||||||
Wister Walcott
|
26,697
|
6,161
|
|
(4)
|
17.15
|
9/6/26
|
33,750
|
|
(5)
|
46,575
|
|||||||||||||
45,000
|
|
(6)
|
62,100
|
||||||||||||||||||||
Robert Bertz
|
20,000
|
|
(7)
|
27,600
|
|||||||||||||||||||
20,000
|
|
(8)
|
27,600
|
||||||||||||||||||||
Bradley Kinnish
|
19,048
|
9,524
|
|
(9)
|
13.30
|
4/6/27
|
—
|
—
|
|||||||||||||||
34,020
|
36,980
|
|
(10)
|
7.40
|
3/6/28
|
—
|
—
|
(1) |
Outstanding equity awards granted prior to March 21, 2013 were granted under our 2006 Plan. Outstanding equity awards granted after March 21, 2013 were granted under our 2013 Plan. All stock options expire
10 years after the date of grant. In general, the unvested shares subject to a stock option will expire prior to the stock option’s stated expiration date in the event of the optionee’s termination of employment. See “Potential Payments
upon Employment Termination and Change in Control Events” for additional information.
|
(2) |
The market value of the unvested shares subject to the RSU awards were computed using $1.38, which was the closing price of our common stock on The Nasdaq Global Market on December 31, 2019.
|
(3) |
The stock option award was granted in May 2019 with a vesting commencement date of May 13, 2019. 25% of the shares of our common stock subject to the stock option will vest on May 13, 2020 with the remaining shares subject to the stock
option vesting on an equal annual basis on each anniversary thereafter so long as Mr. Lien continues to provide services to the company, such that the shares subject to the stock option will be fully vested on May 13, 2023.
|
(4) |
The stock option award was granted in September 2016 with a vesting commencement date of September 7, 2016. 25% of the shares of our common stock subject to the stock option vested on September 7, 2017 with the
remaining shares subject to the stock option vesting monthly over the following three years, such that the shares subject to the stock option will be fully vested on September 7, 2020.
|
(5) |
The shares of our common stock subject to the RSU award vested as to 11,250 of the shares subject to the RSU award on April 12, 2019. The remaining shares subject to the RSU award will vest each quarter
thereafter on an equal quarterly basis over the next three years so long as Mr. Walcott continues to provide services to the company, such that the RSU award will be fully vested on April 12, 2022.
|
(6) |
The shares of our common stock subject to the RSU award will vest as to 25% of the shares subject to the RSU award on May 13, 2020 and the remaining shares subject to the RSU award vest on an equal annual basis on each anniversary
thereafter over the next three years so long as Mr. Walcott continues to provide services to the company, such that the RSU award will be fully vested on May 13, 2023.
|
(7) |
The shares of our common stock subject to the RSU award will vest as to 25% of the shares subject to the RSU award on May 7, 2020 and the remaining shares subject to the RSU award will vest on an equal annual basis on each anniversary
thereafter over the next three years so long as Mr. Bertz continues to provide services to the company, such that the RSU award will be fully vested on May 7, 2023.
|
(8) |
The shares of our common stock subject to the RSU award will vest as to 25% of the shares subject to the RSU award on December 9, 2020 and the remaining shares subject to the RSU award will vest on an equal annual basis on each
anniversary thereafter over the next three years so long as Mr. Bertz continues to provide services to the company, such that the RSU award will be fully vested on December 9, 2023.
|
(9) |
The stock option award was granted in April 2017 with a vesting commencement date of April 7, 2017. 25% of the shares of our common stock subject to the stock option vested on April 7, 2018 with the remaining shares subject to the
stock option vesting monthly over the following three years so long as Mr. Kinnish continues to provide services to the company. Mr. Kinnish resigned from the Company as of December 13, 2019 and the stock option ceased to vest as of such
date.
|
(10) |
The stock option award was granted in March 2018 with a vesting commencement date of March 7, 2018. 25% of the shares of our common stock subject to the stock option vested on March 7, 2018 with the remaining shares subject to the
stock option vesting monthly over the following three years so long as Mr. Kinnish continues to provide services to the company. As a result of Mr. Kinnish’s resignation, the stock option ceased to vest as of the date of resignation.
|
• |
Term: Pursuant to its terms, such agreement became effective on April 12, 2018 and terminates upon the earlier of April 12, 2021 or the date Mr. Lien’s employment is terminated for a reason other than a
“qualifying termination.” A “qualifying termination” is defined as (1) a “change in control qualifying termination”, or a separation occurring within three months preceding or 12 months following a change in control resulting from
termination of Mr. Lien’s employment for any reason other than cause or Mr. Lien voluntarily resigning his employment for good reason; or (2) a separation that is not a “change in control qualifying termination” resulting from termination
of Mr. Lien’s employment for any reason other than cause or Mr. Lien voluntarily resigning his employment for good reason.
|
• |
Termination other than in connection with a change in control. In the event of a termination without cause other than in connection with a change in control, Mr. Lien would be entitled to receive
severance benefits equal to nine months of his then current annual base salary, 75% of his annual target bonus at the then-current rate, and the monthly benefits premium under COBRA for nine months.
|
• |
Termination in connection with a change in control. In the event of a qualifying termination, following a change in control (as defined in the severance
agreement) of our Company, Mr. Lien would be entitled to receive severance benefits equal to 18 months of his then-current annual base salary, 150% of his annual target bonus at the then-current rate, and the monthly benefits premium
under COBRA for 18 months. In addition, the shares underlying all unvested equity awards held by him or her immediately prior to such termination will become vested and exercisable in full.
|
• |
Term: Pursuant to its terms, such agreement was effective on April 12, 2018 and terminates upon the earlier of April 12, 2021 or the date employment is terminated for a reason other than a “qualifying
termination.” A “qualifying termination” is defined as (1) a “change in control qualifying termination”, or a separation occurring within three months preceding or 12 months following a change in control resulting from termination of the
individual’s employment for any reason other than cause or the individual voluntarily resigning his employment for good reason; or (2) a separation that is not a “change in control qualifying termination” resulting from termination of the
individual’s employment for any reason other than cause or the individual voluntarily resigning his employment for good reason.
|
• |
Termination other than in connection with a change in control. In the event of a termination without cause other than in connection with a change in control, the executive would be entitled to receive
severance benefits equal to six months of his then current annual base salary, 50% of the executive’s annual target bonus at the then-current rate, and the monthly benefits premium under COBRA for six months.
|
• |
Termination in connection with a change in control. In the event of a qualifying termination, following a change in control (as defined in the severance agreement) of our Company, the executive would be
entitled to receive severance benefits equal to 12 months of his then-current annual base salary, 100% of the executive’s annual target bonus at the then-current rate, and the monthly benefits premium under COBRA for 12 months. In
addition, the shares underlying all unvested equity awards held by him immediately prior to such termination will become vested and exercisable in full.
|
• |
Term: Pursuant to its terms, such agreement was effective on December 5, 2019 and terminates upon the earlier of December 5, 2022 or the date employment
is terminated for a reason other than a “qualifying termination.” A “qualifying termination” is defined as (1) a “change in control qualifying termination”, or a separation occurring within three months preceding or 12 months following a
change in control resulting from termination of the individual’s employment for any reason other than cause or the individual voluntarily resigning his employment for good reason; or (2) a separation that is not a “change in control
qualifying termination” resulting from termination of the individual’s employment for any reason other than cause or the individual voluntarily resigning his employment for good reason.
|
• |
Termination other than in connection with a change in control. In the event of a termination without cause other than in connection with a change in
control, the executive would be entitled to receive severance benefits equal to three months of his then current annual base salary, 25% of the executive’s annual target bonus at the then-current rate, and the monthly benefits premium
under COBRA for three months.
|
• |
Termination in connection with a change in control. In the event of a qualifying termination, following a change in control (as defined in the severance
agreement) of our Company, the executive would be entitled to receive severance benefits equal to six months of his then-current annual base salary, 50% of the executive’s annual target bonus at the then-current rate, the pro rata portion
of his unpaid annual target bonus for the period of completed service, and the monthly benefits premium under COBRA for six months. In addition, the shares underlying all unvested equity awards held by him immediately prior to such
termination will become vested and exercisable in full.
|
Chris Lien
|
Wister Walcott
|
Robert Bertz
|
||||||||||
Termination after Change of Control:
|
||||||||||||
Cash Severance(1)
|
$
|
1,200,000
|
$
|
450,000
|
$
|
254,063
|
||||||
Post-termination COBRA Reimbursement(2)
|
48,160
|
—
|
11,098
|
|||||||||
Acceleration of Stock Options and RSUs(3)
|
—
|
108,675
|
55,200
|
|||||||||
Total
|
$
|
1,248,160
|
$
|
558,675
|
$
|
320,361
|
||||||
Termination not in connection with Change of Control:
|
||||||||||||
Cash Severance(4)
|
$
|
600,000
|
$
|
225,000
|
$
|
103,125
|
||||||
Post-termination COBRA Reimbursement(5)
|
24,080
|
—
|
5,549
|
|||||||||
Total
|
$
|
624,080
|
$
|
225,000
|
$
|
108,674
|
(1) |
Mr. Lien would receive 18 months of base salary and 150% of his annual target bonus. Mr. Walcott would receive 12 months of base salary and 100% of his annual target bonus. Mr. Bertz would receive six
months of base salary, 50% of his annual target bonus and the pro rata portion of his unpaid annual target bonus for the period of completed service.
|
(2) |
Mr. Lien would receive 18 months of COBRA benefits reimbursement and Mr. Bertz would receive six months of COBRA benefits reimbursement. Mr. Walcott elected not to receive benefits from the Company that would be eligible for continuation under COBRA. As a result, Mr. Walcott would not be eligible for post-termination COBRA benefits reimbursement.
|
(3) |
As of December 31, 2019, Mr. Walcott held a stock option with 13,006 unvested shares subject to such option with an exercise price of $17.15 per share. The exercise price of each of these stock options is
greater than $1.38, the closing price of our common stock on The Nasdaq Global Market as of December 31, 2019. As of December 31, 2019, Mr. Walcott had 78,750 unvested RSUs and Mr. Bertz had 40,000 unvested RSUs.
|
(4) |
Mr. Lien would receive nine months of base salary and 75% of his annual target bonus; Mr. Walcott would receive six months of base salary and 50% of his target bonus; Mr. Bertz would receive three months of base
salary and 25% of his target bonus.
|
(5) |
Mr. Lien would receive nine months of COBRA benefits reimbursement and Mr. Bertz would receive three months of COBRA benefits reimbursement. Mr. Walcott elected not to receive benefits from the Company that
would be eligible for continuation under COBRA. As a result, Mr. Walcott would not be eligible for post-termination COBRA benefits reimbursement.
|
Plan category
|
Number of
securities to
be issued
upon exercise
of outstanding
options and
restricted
stock units(#)
|
Weighted-
average exercise
price of
outstanding
options ($)
|
Number of securities
remaining available for
future issuance under
equity compensation
plans (excluding
securities reflected in
column(a))(#)
|
|||||||||
(a)
|
(b)
|
(c)
|
||||||||||
Equity compensation plans approved by security holders
|
1,604,595
|
(1)
|
23.38
|
(2)
|
856,095
|
(3)
|
||||||
Equity compensation plans not approved by security holders
|
—
|
—
|
—
|
|||||||||
Total
|
1,604,595
|
23.38
|
856,095
|
(1) |
Excludes purchase rights accruing under the 2013 ESPP.
|
(2) |
The weighted average exercise price relates solely to shares subject to outstanding stock options, as shares subject to restricted stock units have no exercise price.
|
(3) |
Consists of 137,713 shares that remain available for purchase under the 2013 ESPP and 718,382 shares of common stock that remain available for grant under the 2013 Plan. Any such shares of common stock that are
subject to outstanding awards under the 2006 Plan that are issuable upon the exercise of options that expire or become unexercisable for any reason without having been exercised in full will be forfeited and will be available for future
grant and issuance under the 2013 Plan. In addition, the number of shares reserved for issuance under our 2013 Plan will increase automatically on the first day of January of each of 2021 through 2023 by the number of shares equal to the
lesser of 5% of the total outstanding shares of our common stock as of the immediately preceding December 31st and a number of shares approved by our Board.
Similarly, the number of shares reserved for issuance under our 2013 ESPP will increase will increase automatically on the first day of January of each of 2021 through 2023 by the number of shares equal to the lesser of 1% of the total
outstanding shares of our common stock as of the immediately preceding December 31st (rounded down to the nearest whole share) and a number of shares
approved by our Board or our compensation committee.
|